Virulizin-2gamma, a novel immunotherapeutic agent, in treatment of human pancreatic cancer xenografts. [electronic resource]
- International journal of oncology May 2000
- 1015-20 p. digital
Publication Type: Journal Article
1019-6439
10.3892/ijo.16.5.1015 doi
Adjuvants, Immunologic--administration & dosage Animals Antineoplastic Combined Chemotherapy Protocols--therapeutic use Bile Deoxycytidine--analogs & derivatives Drug Evaluation, Preclinical Humans Immunologic Factors--therapeutic use In Vitro Techniques Mice Mice, Nude Pancreatic Neoplasms--drug therapy Spleen--immunology T-Lymphocytes--immunology Tissue Extracts Gemcitabine